Q2 2021 Holdings
Filed 2021-08-16 | 34 holdings | $95.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $23.2M | 380,928 | 24.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $20.9M | 760,164 | 21.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $18.8M | 561,398 | 19.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $13.7M | 178,500 | 14.4% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $11.8M | 403,523 | 12.4% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $6.5M | 982,753 | 6.9% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $79.4K | 1,256,265 | 0.1% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $79.2K | 943,156 | 0.1% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $28.9K | 3,582,629 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $20.0K | 831,267 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $19.4K | 109,335 | 0.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $15.0K | 1,132,671 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $14.1K | 112,363 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $12.3K | 583,649 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $11.5K | 1,413,138 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $11.0K | 446,641 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $10.0K | 296,822 | 0.0% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $8.8K | 450,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $8.5K | 250,000 | 0.0% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $7.3K | 373,492 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $6.8K | 320,440 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $5.6K | 400,000 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $5.4K | 238,045 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $5.0K | 250,000 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $4.9K | 200,000 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $4.9K | 100,000 | 0.0% |
| Merus N V | COM | N5749R100 | $4.4K | 206,927 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $4.3K | 680,036 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $4.1K | 400,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $4.0K | 126,136 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $3.9K | 200,000 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $3.5K | 146,173 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $3.0K | 300,000 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $2.7K | 125,000 | 0.0% |